Angiostatin fragments in urine from patients with malignant disease

Anticancer Research

Volumn 19, Issue 4 C, 1999, Pages 3409-3414

  Sten Linder, Margareta ^a,c   Linder, Christina ^b   Strander, Hans ^a   Munck Wikland, Eva ^c   Wersäll, Peter ^a   Linder, Stig ^b   Wiman, Björn ^a  

^a Dept Clin Chem and Blood Coagul ^*  (Sweden)

^b Research Laboratory Radiumhemmet   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiostatin; Cancer patients; Kidney function; Urine

Indexed keywords

ANGIOSTATIN; PLASMINOGEN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ARTICLE; CANCER; DENSITOMETRY; HUMAN; IMMUNOBLOTTING; KIDNEY FUNCTION; KRINGLE DOMAIN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; URINE;

ALBUMINURIA; ALPHA-GLOBULINS; AMINO ACID SEQUENCE; ANGIOSTATINS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHEMILUMINESCENT MEASUREMENTS; DENSITOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; KIDNEY NEOPLASMS; KRINGLES; LUNG NEOPLASMS; MESOTHELIOMA; MOLECULAR SEQUENCE DATA; NEOPLASMS; PEPTIDE FRAGMENTS; PLASMINOGEN; PROGNOSIS; SARCOMA;

EID: 0033430199     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fidler IJ and Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis.Cell 79: 185-188, 1994.
2. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1: 27-31, 1995.
3. Hanahan D and Folkman J: Patterns and Emerging Mechanisms of the Angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
4. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328, 1994.
5. Cao Y, Ji RW, Davidson D, Schaller J, Marti D, Söhndel S, McCance SG, O'Reilly MS, Llin's M and Folkman J: Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem 271: 29461-29467, 1996.
6. O'Reilly MS, Holmgren L, Chen C and Folkman J: Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Medicine 2: 689-692, 1996.
7. Lannutti BJ, Gately ST, Quevedo ME, Soff GA, Paller AS: Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. Cancer Res 57: 5277-5280, 1997.
8. Sim BK, O'Rheilly MS, Liang H, Fortier AH, He W, Madsen JW, Lapcevich R and Nacy CA: A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 57: 1329-1334, 1997.
9. Cao YH, O'Reilly MS, Marshall B, Flynn E, Ji RW, Folkman J: Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary growth and produces long-term dormancy of metastases. J Clin Invest 101: 1055-1063, 1998.
10. Cao YH, Chen A, An SSA, Ji RWD, Davidson D, Cao YM and Llinas M: Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem 272: 22924-22928, 1997.
11. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR and Folkman J: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997.
12. Wiman B, Boman L, Collen D: On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin. Eur J Biochem 87: 143-146, 1978.
13. Sternberg JC: A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin Chem 23: 1456-1464, 1977.
14. Dong Z, Kumar R, Yang X, and Fidler IJ: Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88: 801-810, 1997.
15. Patterson BC and Sang QXA: Angiostatin-coverting enzyme activities of human matrilysin (MMP-7) and gelatinase B type IV collagenase (MMP-9). J Biol Chem 272: 28823-28825, 1997.
16. Lijnen HR, Ugwu F, Bini A, Collen D: Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37: 4699-4702, 1998.
17. Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, Enghild J, Kwaan HC, Lee F, Kramer RA, Volpert O, Bouck N and Soff GA: The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci USA 94: 10868-10872, 1997.
18. Stathakis P, Fitzgerald M, Matthias LJ, Chesterman CN and Hogg PJ: Generation of angiostatin by reduction and proteolysis of plasmin - catalysis by a plasmin reductase secreted by cultured cells. J Biol Chem 272: 20641-20645, 1997.